research Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.
Search
for
Sort by
Research
90-120 / 1000+ results 
research Chronic telogen effluvium in a man
The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.
research Peculiar hypertrichosis in a patient affected by frontal fibrosing alopecia with pseudo "fringe sign"
A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.
research Diffuse hair loss in females
Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.
research 222 Severe COVID-19 infection predisposes patients to greater burden of hair loss
People who had severe COVID-19 are more likely to experience hair loss.
research Frontal fibrosing alopecia: a pathology on the rise
Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.
research Localized Telogen Effluvium Following Hair Transplantation
Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.
research Characteristics of telogen effluvium in COVID-19 in western Iran (2020)
COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.
research Mujer con caída de cabello en el posparto
Postpartum hair loss usually stops within 4-6 months.
research Telogen effluvium
Telogen effluvium is a condition that causes temporary hair loss.
research Female pattern hair loss
Female pattern hair loss is common in women, treatable with medications, and can affect mental health.
research Hair loss after covid 19 - case series
COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.
research Investigating self-reported hair loss following covid-19 infection in the Iraqi population
COVID-19 may cause hair loss, especially in young adults.
research COVID-19-associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study.
Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
research Hair Loss as a Late Complication of Multisystem Inflammatory Syndrome in Children
Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.
research A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation
COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.
research Head Disorders: Telogen Effluvium
Telogen effluvium causes temporary hair loss, but new hair still grows.
research Postmenopausal frontal fibrosing alopecia
Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.
research The increasing incidence of frontal fibrosing alopecia. In search of triggering factors
Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.
research Female Pattern Hair Loss May Need More Finasteride
research Telogen Effluvium as a Sign of Hodgkin Disease
Hair loss may be an early sign of serious illnesses like Hodgkin disease.
research Alopecias Due to Drugs and Other Skin and Systemic Disorders
Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.
research Female pattern hair loss in clinic
research ACUTE TELOGEN EFFLUVIUM FOLLOWING SARS-COV-2 INFECTION: A RARE PEDIATRIC CASE
A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.
research Male frontal fibrosing alopecia with generalised hair loss
A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.
research Steven Kossards postmenopausal frontal fibrosing alopecia (PFFA)--a therapeutic dilemma.
Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.
research Telogen Effluvium
Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.
research Hair loss following COVID-19 infection - the state of current knowledge and treatment approaches.
COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.
research Hair Disorders
The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.
research POST COVID-19 TELOGEN EFFLUVIUM. WHAT IS THE REASON?
Post-COVID-19 hair loss is likely due to stress and inflammation.